Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-09, Stock:JNJ, The news for the past five days is as follows:
2019-10-02: NEWS1: Pharma Giant J&J Avoids Opioid Trial In Ohio With $20.4 Million Payout.NEWS2: Johnson & Johnson Is the Only Dow Stock Trading Higher Wednesday. Here’s Why..NEWS3: Johnson & Johnson settles with Ohio for $20.4M prior to opioid trial.NEWS4: Johnson & Johnson claim judge miscalculated by over $100 million in opioid case.NEWS5: Sell-Side Positive On Johnson & Johnson's Unexpected Ohio Opioid Settlement.NEWS6: US STOCKS-Wall Street tumbles as trade war threatens U.S. economy.NEWS7: The Market Tells Opioid Drugmakers to Settle Up.NEWS8: Midday Wrap: Here's Why Johnson & Johnson Is Bucking Dow Selloff.NEWS9: [video]Stocks Finish Down Sharply as Wall Street Gets Recession Jitters.NEWS10: Stocks - S&P Sees Worst Loss Since August on Global Economic Fears.NEWS11: Johnson & Johnson settles Ohio suits.NEWS12: [video]Dow Sinks as Wall Street Gets Recession Jitters.NEWS13: US STOCKS-Wall Street drops more than 1% on domestic growth worries.NEWS14: Dow Jones Breaks Below Key Support Level On Mounting Recessions Fears.NEWS15: Johnson & Johnson's stock the lone Dow gainer after opioid-related settlement with Ohio counties.NEWS16: Abiomed's (ABMD) Impella 5.5 With SmartAssist Gets FDA Nod.NEWS17: Johnson & Johnson Has Struck a Deal to Avoid a Key Opioid Trial.NEWS18: [video]Dow's Slide Gains Momentum as Recession Worries Grip Wall Street.NEWS19: Johnson & Johnson Shares Gain After $20 Million Opioid Settlement in Ohio.NEWS20: The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data.NEWS21: Market Morning: Economy Stalling, Libra Letdown, J&J Settles, Impeachment Heats Up.NEWS22: NewsBreak: Wall Street Drubbing Continues; Dow Tumbles 450.NEWS23: [video]Dow Falters Under Grim Factory Data, Recession Fears, Slowing Jobs Growth.NEWS24: Johnson & Johnson, Facebook's Libra, Exxon, Lennar - 5 Things You Must Know.NEWS25: FirstFT: Today’s top stories.NEWS26: Johnson & Johnson settles two Ohio opioid suits for $20 million.NEWS27: UPDATE 2-Johnson & Johnson settles Ohio lawsuits to avoid federal trial.NEWS28: [video]Johnson & Johnson Settles Opioid Suits With Two Ohio Counties for $20.4 Million.NEWS29: J&J settles with Ohio counties ahead of opioid trial.
2019-10-03: NEWS1: Here is Hedge Funds’ 5th Most Popular Stock Pick.NEWS2: Pres. Trump to expand private Medicare Advantage program.NEWS3: European and US Markets Decline Sharply on Wednesday.NEWS4: J&J Settles Ahead of Multi-District Opioid Trial, Stock Up.NEWS5: Company News For Oct 3, 2019.NEWS6: Novartis Reports Additional Data on Spondylitis Drug Cosentyx.
2019-10-04: NEWS1: Dr. Fred Moll predicts future of robotic surgery industry, explains why he sold Auris Health.NEWS2: Apple Inc., Merck share gains lead Dow's 279-point rally.NEWS3: Apple Inc., Travelers share gains lead Dow's 200-point climb.NEWS4: Pharma Stock Roundup: JNJ's Opioid Settlement, FDA Updates for AZN, GSK, MRK, RHHBY.NEWS5: J&J Gets Breakthrough Therapy Tag for Prostate Cancer Drug.NEWS6: Apple Inc., Visa share gains lead Dow's 138-point climb.NEWS7: Johnson & Johnson commits $500 million over four years to help end HIV, TB epidemics.NEWS8: The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering.NEWS9: Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis.
2019-10-07: NEWS1: Walmart, Travelers share losses lead Dow's nearly 50-point fall.NEWS2: Theravance Pipeline Strong, Dependence on Yupelri a Concern.NEWS3: The Zacks Analyst Blog Highlights: J&J, AstraZeneca, Roche, Glaxo and Merck.NEWS4: Johnson & Johnson Releases Inaugural You Belong: Diversity & Inclusion Impact Review.
2019-10-08: NEWS1: UPDATE 3-Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.99%: What You Should Know.NEWS3: J&J must pay $8 bln in case over male breast growth linked to Risperdal -jury.NEWS4: [video]Johnson & Johnson Shares Fall After Hours on $8 Billion Jury Award.NEWS5: Is Johnson & Johnson (JNJ) A Good Stock To Buy According To Hedge Funds?.NEWS6: Teen beauty spending plunges 20% from last year to a 9-year low.NEWS7: Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline.NEWS8: Johnson & Johnson hit with $8bn court order over antipsychotic drug.

Answer: Decrease